248 related articles for article (PubMed ID: 1973467)
41. Update on peptic ulcer drugs.
Aronson B
Am J Nurs; 1998 Jan; 98(1):41-6. PubMed ID: 9455332
[No Abstract] [Full Text] [Related]
42. [Current locally acting agents in the treatment of peptic ulcer].
Ryss ES
Klin Med (Mosk); 1986 Aug; 64(8):18-27. PubMed ID: 2878103
[No Abstract] [Full Text] [Related]
43. [Long-term therapy of gastroduodenal ulcer disease].
Hahn L
Z Arztl Fortbild (Jena); 1993; Suppl 1():1-3. PubMed ID: 7901947
[No Abstract] [Full Text] [Related]
44. Peptic ulcers in the elderly: unique features and management.
Freston MS; Freston JW
Geriatrics; 1990 Jan; 45(1):39-42, 45. PubMed ID: 2403956
[TBL] [Abstract][Full Text] [Related]
45. [The interaction potential of H2 receptor antagonists. A short current review].
Klotz U; Kroemer HK
Fortschr Med; 1991 Sep; 109(28):574-6. PubMed ID: 1684557
[No Abstract] [Full Text] [Related]
46. Prevention of NSAID-induced GI mucosal injury.
Gerritz S; Newton WP
J Fam Pract; 1997 Feb; 44(2):130-1. PubMed ID: 9040509
[No Abstract] [Full Text] [Related]
47. [Complementary medicine. Phytotherapy in gastrointestinal ulcer].
Praxis (Bern 1994); 2004 Apr; 93(16):682-3. PubMed ID: 15127989
[No Abstract] [Full Text] [Related]
48. [Clinical aspects of Kvamatel (famotidine) administration].
Golochevskaia VS
Klin Med (Mosk); 1996; 74(1):45-7. PubMed ID: 8649009
[No Abstract] [Full Text] [Related]
49. [Prevention of stress ulcer: an essentially necessary measure in intensive care patients? Arguments pro].
Gyr NE; Meier R
Z Gastroenterol; 1991 Jan; 29 Suppl 1():4-6; discussion 9. PubMed ID: 1683734
[No Abstract] [Full Text] [Related]
50. [Antagonists of the histamine H2 receptors in the stomach].
Landa L
Gac Med Mex; 1981 Dec; 117(12):472-4. PubMed ID: 6123460
[No Abstract] [Full Text] [Related]
51. Role of protective drugs in the prevention of ulcer relapse.
Ota S; Terano A
J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
[TBL] [Abstract][Full Text] [Related]
52. Drug therapy of peptic ulcer disease.
Ching CK; Lam SK
Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
[TBL] [Abstract][Full Text] [Related]
53. [Peptic ulcer--advances in drug therapy].
Gütz HJ
Z Arztl Fortbild (Jena); 1990; 84(16):811-3. PubMed ID: 1977243
[No Abstract] [Full Text] [Related]
54. Current concepts in clinical therapeutics: peptic ulcer disease.
Siepler JK; Mahakian K; Trudeau WT
Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
[TBL] [Abstract][Full Text] [Related]
55. [What is the role of H2 receptor blockers today in ulcer therapy?].
Creutzfeldt W
Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690
[No Abstract] [Full Text] [Related]
56. Medical treatment of peptic ulcer.
Habeebullah CM; Prabhakar B
Trop Gastroenterol; 1994; 15(2):65-75. PubMed ID: 7831720
[No Abstract] [Full Text] [Related]
57. [Treatment of peptic disorders: are all drugs permitted?].
Loizeau E
Rev Med Suisse Romande; 1989 Oct; 109(10):837-9. PubMed ID: 2573136
[No Abstract] [Full Text] [Related]
58. Pharmacologic antagonists to gastric acid secretion.
Dinoso VP
Compr Ther; 1978 Jul; 4(7):40-3. PubMed ID: 27329
[No Abstract] [Full Text] [Related]
59. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
60. [Peptic ulcer: a social and therapeutic problem still current].
Visconti GP; Spotti D; Vigorelli PE; Geniram A
Recenti Prog Med; 1979 Nov; 67(5):530-45. PubMed ID: 42955
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
